期刊文献+

再同步化治疗对改善左室舒张末期内径疗效的分析 被引量:1

Analysis on improvement of left ventricular end diastolic diameter after cardiac resynchronization therapy
暂未订购
导出
摘要 目的探讨对再同步化治疗(CRT)后左室舒张末期内径(LVEDd)改善有影响作用的因素。方法选取在鼓楼医院成功植入CRT的43例患者,搜集其术前、术后6个月随访的资料,通过相关性分析、t检验、方差分析、多元回归分析,筛选出最能影响术后LVEDd改善程度的因素。结果单因素分析显示,年龄、病程,基础心电图的QRS时限、是否患有高血压、糖尿病,性别,是否为缺血性心肌病,术前的LVEDd,术前心电图是否为左束支传导阻滞,左室电极的位置,二尖瓣返流程度均对LVEDd的改善程度无显著的影响。多元线性回归分析显示,术前LVEDd、性别、是否有糖尿病3个因素与LVEDd的改善程度线性相关,其回归系数分别为-0.17(P=0.026)、-0.23(P=0.052)和-0.18(P=0.084)。结论术前的LVEDd、性别、糖尿病史与术后LVEDd改善程度线性负相关,相关程度较弱,但具有一定的预测作用。 Objective To explore the factors which can impact the improvement of left ven- tricular end diastolic diameter (LVEDd) after cardiac resynchronization therapy (CRT). Methods Forty-three patients who suffered from chronic heart failure and were implanted CRT in our hospital were enrolled in the study. Data of preoperative period and six months after CRT were collected. Several statistic methods, such as correlation analysis, t-test, ANOVA, multivariate regression anal- ysis, were used to identify which factor could influence the improvement of LVEDd. Results Sin- gle factor analysis demonstrated that age, duration of disease, preoperative QRS wave duration of preoperation, hypertension, diabetes, sex, ischemic cardiomyopathy, LVEDd of preoperation, left bundle branch block, electrode position of left ventricular and the extent of mitral regurgitation did not impact the improvement of LVEDd significantly. However, multivariate regression analysis re- vealed that LVEDd of preoperation, sex and diabetes history were linear correlated with improve- ment of LVEDd. The regression coefficient were - 0.17(P = 0. 026), - 0.23(P = 0. 052) and - 0.18 (P = 0. 084) respectively. Conclusion The LVEDd of preoperation, sex and diabetes history are negative linear correlated with improvement of LVEDd after CRT, which can have predictive value, although the relation is weak.
出处 《实用临床医药杂志》 CAS 2013年第1期13-16,共4页 Journal of Clinical Medicine in Practice
关键词 再同步化 左室舒张末期内径 改善 线性相关 resynchronizationi left ventricular end diastolic diameterl improvement linear correlation
  • 相关文献

参考文献12

  • 1Abraham W T,Young J B,Len A R. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction,an indication for an implantable cardioverter-defibrillator and mildly symptomatic chronic heart failure[J].Circulation,2004.2864.
  • 2Bertoldi E G,Polanczyk C A,Cunha V. Mortality reduction of cardiac resynchronization and implantable cardioverter-defibrillator therapy in heart failure:an updated meta-analysis.Does recent evidence change the standard of care[J].Journal of Cardiac Failure,2011,(10):860.
  • 3Dickstein K,Vardas P E,Auricchio A. 2010 Focused Update of ESC Guidelines on device therapy in heart failure:an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy.Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association[J].European Heart Journal,2010,(21):2677.
  • 4Cleland J G,Daubert J C,Erdmann E. The effect of cardiac resynchronization on morbidity and mortality in heart failure[J].New England Journal of Medicine,2005,(15):1539.
  • 5Hunt S A,Abraham W T,Chin M H. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult[J].Circulation,2005,(12):e154.
  • 6Ilan Goldenberg,Arthur J.Moss,W.Jackson Hall. Predictors of response to cardiac resynchronization therapy in the multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy (MADIT-CRT)[J].Circulation,2011.1527.
  • 7惠玲玲,张卫泽,陈永清,马凌,韩娟萍,张玉秀.左心室大小和术后收缩压变化与心脏再同步化治疗疗效的关系[J].心脏杂志,2011,23(6):741-743. 被引量:3
  • 8Natália,Rogério,Loureno. Identification of "super-responders" to cardiac resynchronization therapy:the importance of symptom duration and left ventricular geometry[J].Europace:European Pacing,Arrhythmias and Cardiac Electrophysiology,2009.343.
  • 9巩雪,宿燕岗,潘文志,崔洁,潘翠珍,王蔚,柏瑾,秦胜梅,葛均波,舒先红.常用临床和超声指标对心脏再同步化治疗效果的预测价值[J].中华临床医师杂志(电子版),2011,5(2):34-38. 被引量:10
  • 10Berger R,Shankar A,Fruhwald F. Relationships between cardiac resynchronization therapy and N-terminal probrain natriuretic peptide in patients with heart failure and markers of cardiac dyssynchrony:an analysis from the Cardiac Resynchronization in Heart Failure (CARE-HF) study[J].European Heart Journal,2009,(17):2109.

二级参考文献6

共引文献11

同被引文献21

  • 1王冬梅,臧红云,韩雅玲,周微微,荆全民,王祖禄,王守力,李菲.心脏再同步治疗对不同病因的充血性心力衰竭的长期疗效[J].中国介入心脏病学杂志,2006,14(2):80-82. 被引量:4
  • 2Nery P B, Keren A, Birnie D H. Cardiac resynchroniza- tion therapy: expanding clinical indications and refining patient selection [ J ]. Curr Opin C ardiol, 2012,27 ( 2 ) : 137-142.
  • 3Barsheshet A, Goldenberg I, Moss A J, et al. Response to preventive cardiac resynchronization therapy in patients with ischaemic and nonischaemic cardiomyopathy in MA- DIT-CRT[ J]. Eur Heart J, 2011,32(13) :1622-1630.
  • 4Stahlberg M, Lund L H, Zabarovskaja S, et al. Cardiac resynchronization therapy: a breakthrough in heart failure management[J]. J Intern Med, 2012,272(4) :330-343.
  • 5Gabrielli L, Sitges M, Mont L. Assessing reverse remod- eling in heart failure patients treated with cardiac resyn- chronization therapy and its impact on prognosis [ J ]. Expert Rev Cardiovasc Ther, 2012,10 ( 11 ) : 1437-1448.
  • 6Epstein A E, DiMarco J P, Ellenbogen K A, et al. ACC/ AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Re- vise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American As- sociation for Thoracic Surgery and Society of Thoracic Sur- geons[J]. J Am Coll Cardiol, 2008,51 (21) :e1-e62.
  • 7Adabag S, Roukoz H, Anand I S, et al. Cardiac resyn- chronization therapy in patients with minimal heart failure: a systematic review and meta-analysis [ J ]. J Am Coil Cardiol, 2011,58 ( 9 ) : 935- 941.
  • 8Steffel J, Holzmeister J, Abraham W T. Recent advances in cardiac resynchronization therapy [ J ]. Postgrad Med, 2011,123 (2) :18-26.
  • 9Rossi A, Rossi G, Piacenti M, et al. The current role of cardiac resynchronization therapy in reducing mortality and hospitalization in heart failure patients: a meta-analy- sis from clinical trials [ J ]. Heart Vessels, 2008,23 ( 4 ) : 217-223.
  • 10Barsheshet A, Moss A J, Eldar M, et al. Time-depend- ent benefit of preventive cardiac resynchronization therapy after myocardial infarction [ J ]. Eur Heart J, 2011,32 (13) :1614-1621.

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部